Sarah Zohar
Title
Cited by
Cited by
Year
Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis
MC Vonk, Z Marjanovic, FHJ van den Hoogen, S Zohar, ...
Annals of the rheumatic diseases 67 (1), 98-104, 2008
1902008
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma
A Carpentier, F Laigle-Donadey, S Zohar, L Capelle, A Behin, A Tibi, ...
Neuro-oncology 8 (1), 60-66, 2006
1872006
Opioid abuse and dependence during pregnancytemporal trends and obstetrical outcomes
A Maeda, BT Bateman, CR Clancy, AA Creanga, LR Leffert
The Journal of the American Society of Anesthesiologists 121 (6), 1158-1165, 2014
1512014
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
A Carpentier, P Metellus, R Ursu, S Zohar, F Lafitte, M Barrie, Y Meng, ...
Neuro-oncology 12 (4), 401-408, 2010
1472010
Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial
RM Pressler, GB Boylan, N Marlow, M Blennow, C Chiron, JH Cross, ...
The Lancet Neurology 14 (5), 469-477, 2015
1422015
Dose‐finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method
L Desfrere, S Zohar, P Morville, A Brunhes, S Chevret, G Pons, G Moriette, ...
Journal of clinical pharmacy and therapeutics 30 (2), 121-132, 2005
1312005
Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I–II study
D Farge, JP Marolleau, S Zohar, Z Marjanovic, J Cabane, N Mounier, ...
British journal of haematology 119 (3), 726-739, 2002
1222002
The continual reassessment method: comparison of Bayesian stopping rules for dose‐ranging studies
S Zohar, S Chevret
Statistics in medicine 20 (19), 2827-2843, 2001
1092001
Experimental designs for phase I and phase I/II dose-finding studies
J O'Quigley, S Zohar
British journal of cancer 94 (5), 609-613, 2006
772006
Late morbidity after colon interposition for corrosive esophageal injury: risk factors, management, and outcome. A 20-years experience
M Chirica, N Veyrie, N Munoz-Bongrand, S Zohar, B Halimi, M Celerier, ...
Annals of surgery 252 (2), 271-280, 2010
762010
Risk factors for conversion and complications after unilateral laparoscopic adrenalectomy
S Gaujoux, S Bonnet, M Leconte, S Zohar, J Bertherat, X Bertagna, ...
British journal of surgery 98 (10), 1392-1399, 2011
722011
A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia
V Levy, S Zohar, C Bardin, A Vekhoff, D Chaoui, B Rio, O Legrand, ...
British journal of cancer 95 (3), 253-259, 2006
572006
Surgery for caustic injuries of the upper gastrointestinal tract
M Chirica, M Resche-Rigon, NM Bongrand, S Zohar, B Halimi, JM Gornet, ...
Annals of surgery 256 (6), 994-1001, 2012
542012
Recent developments in adaptive designs for phase I/II dose-finding studies
S Zohar, S Chevret
Journal of biopharmaceutical statistics 17 (6), 1071-1083, 2007
452007
Dose‐finding approach for dose escalation with overdose control considering incomplete observations
A Mauguen, MC Le Deley, S Zohar
Statistics in medicine 30 (13), 1584-1594, 2011
442011
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: results from the ANTHALYA trial
R Rouzier, S Gouy, F Selle, E Lambaudie, A Floquet, V Fourchotte, ...
European Journal of Cancer 70, 133-142, 2017
432017
Colopharyngoplasty for the treatment of severe pharyngoesophageal caustic injuries: an audit of 58 patients
M Chirica, C de Chaisemartin, N Goasguen, N Munoz-Bongrand, S Zohar, ...
Annals of surgery 246 (5), 721-727, 2007
412007
Incorporating lower grade toxicity information into dose finding designs
A Iasonos, S Zohar, J O'Quigley
Clinical Trials 8 (4), 370-379, 2011
382011
Designs of drug-combination phase I trials in oncology: a systematic review of the literature
MK Riviere, C Le Tourneau, X Paoletti, F Dubois, S Zohar
Annals of Oncology 26 (4), 669-674, 2015
372015
A Bayesian dose‐finding design for drug combination clinical trials based on the logistic model
MK Riviere, Y Yuan, F Dubois, S Zohar
Pharmaceutical statistics 13 (4), 247-257, 2014
372014
The system can't perform the operation now. Try again later.
Articles 1–20